Patents by Inventor Konrad Lerch

Konrad Lerch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080166451
    Abstract: A coffee product derived from roast and ground coffee beans has reduced levels of chlorogenic acid lactones relative to the levels of chlorogenic acids. The product can be prepared by treating a coffee extract with an enzyme so as to hydrolyse at least a portion of the chlorogenic acid lactones present in the extract. Alternatively or additionally, it may be provided by contacting a coffee extract with a sorbent or solvent which is suitable for removing apolar components and is at least partially saturated with chlorogenic acid. The product has reduced bitterness.
    Type: Application
    Filed: April 28, 2006
    Publication date: July 10, 2008
    Applicant: NESTEC S.A.
    Inventors: Rachid Bel-Rhlid, Karin Kraehenbuehl, Konrad Lerch, Robert Aeschbach
  • Patent number: 7144715
    Abstract: A process of obtaining ?-keto butyrate by bioconversion is disclosed. The molecule is accumulated in the medium and is apt to subsequent processing to food ingredients, such as top-note flavors. A suitable strain is a natural ilv-3 mutant Neurospora crassa strain, which is capable of accumulating ?-keto butyrate in the fermentation medium. By adjusting specific medium parameters, up to 8 g/l medium of ?-keto butyrate can be accumulated.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: December 5, 2006
    Assignee: Nestec S.A.
    Inventors: Beat Denis Zurbriggen, Nadji Rekhif, Mara Mehlmann-De-Campos, Konrad Lerch
  • Publication number: 20040214298
    Abstract: A process of obtaining &agr;-keto butyrate by bioconversion is disclosed. The molecule is accumulated in the medium and is apt to subsequent processing to food ingredients, such as top-note flavors. A suitable strain is a natural ilv-3 mutant Neurospora crassa strain, which is capable of accumulating &agr;-keto butyrate in the fermentation medium. By adjusting specific medium parameters, up to 8 g/l medium of &agr;-keto butyrate can be accumulated.
    Type: Application
    Filed: May 14, 2004
    Publication date: October 28, 2004
    Inventors: Beat Denis Zurbriggen, Nadji Rekhif, Mara Mehlmann-De-Campos, Konrad Lerch
  • Patent number: 6238898
    Abstract: The present invention relates to the production of HPO lyase proteins in hosts via recombinant expression of said proteins. Recombinant HPO lyase proteins, DNA sequences encoding these proteins, vectors containing these DNA sequences and hosts containing these vectors are provided, along with methods for recombinantly producing such proteins, DNA sequences, vectors and hosts. Also provided are processes for producing green note compounds.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: May 29, 2001
    Assignee: Givaudan Roure (International) SA
    Inventors: Alex Häusler, Konrad Lerch, Andreas Muheim, Natasha Silke
  • Patent number: 6008034
    Abstract: The present invention relates to the production of HPO lyase proteins in hosts via recombinant expression of said proteins. Recombinant HPO lyase proteins, DNA sequences encoding these proteins, vectors containing these DNA sequences and hosts containing these vectors are provided, along with methods for recombinantly producing such proteins, DNA sequences, vectors and hosts. Also provided are processes for producing green note compounds.
    Type: Grant
    Filed: April 7, 1997
    Date of Patent: December 28, 1999
    Assignee: Givaudan-Roure (International) SA
    Inventors: Alex Hausler, Konrad Lerch, Andreas Muheim, Natasha Silke
  • Patent number: 5449823
    Abstract: Two optically active forms of 4-hydroxy-3-methyl-2-keto-pentanoic acid of the formula ##STR1## wherein carbon atom 4 has the (S)-configuration, and carbon atom 3 can have the (R)-configuration or the (S)-configuration (compound I) are made using a biotransformation process. Compound I may be manufactured by reacting 4-hydroxy-isoleucine (2S, 3R, 4S) of the formula: ##STR2## with microorganisms which have L-amino acid oxidase activity or with an L-amino acid oxidase. Compound I is a flavor precursor and may also be used as an intermediate for the production of the optically active (5S)-3-hydroxy-4,5-dimethyl-2(5H)-furanone: ##STR3## which is useful as a flavorant.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: September 12, 1995
    Assignee: Givaudan-Roure Corporation
    Inventor: Konrad Lerch